FDA Approves Updated COVID-19 Vaccines Targeting Omicron Variant
WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) has approved and granted emergency use authorization for the latest mRNA COVID-19 vaccines, formulated for the 2024-2025 period. This update …
FDA Approves Updated COVID-19 Vaccines Targeting Omicron Variant Read More